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Abstract
Two commercially available MALDI-TOF MS systems, Bruker MS and Shimadzu MS, were compared for the identiﬁcation of clinically
relevant anaerobic bacteria. A selection of 79 clinical isolates, representing 19 different genera, were tested and compared with identiﬁ-
cation obtained by 16S rRNA gene sequencing. Correct genus identiﬁcation was achieved for 71% of isolates by Shimadzu MS and for
61% by Bruker MS. Correct identiﬁcation at the species level occurred in 61% and 51%, respectively. Shimadzu showed markedly better
results for identiﬁcation of Gram-positive anaerobic cocci. In contrast, the Bruker system performed better than Shimadzu for the Bac-
teroides fragilis group. When strains not present in the database were excluded from the analyses for each database, both systems per-
formed equally well, with 76.7% and 75.0% correct genus identiﬁcation for Shimadzu and Bruker, respectively. Similarly, when the most
recently updated Bruker database was applied, no difference was observed. We conclude that the composition and quality of the data-
base is crucial for a correct identiﬁcation. The databases currently available for both systems need to be optimized before MS can be
implemented for routine identiﬁcation of anaerobic bacteria.
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Introduction
The identiﬁcation of anaerobic bacteria in routine diagnostics
is difﬁcult and time consuming [1]. To obtain more accurate
and rapid identiﬁcation, molecular methods have been
developed, such as ﬂuorescent in situ hybridization [2] and
PCR-based diagnostics [3]. Recently, matrix-assisted laser
desorption and ionisation-time-of-ﬂight mass spectrometry
(MALDI-TOF MS) has been introduced as a rapid and reli-
able identiﬁcation method for routine application in diagnos-
tic laboratories. Several studies have found MALDI-TOF MS
to be a promising tool for the identiﬁcation of anaerobic
bacteria [4–6]. However, the majority of studies that com-
pared MALDI-TOF identiﬁcation with a reference standard,
contained low numbers of anaerobic species and/or used
conventional phenotypic identiﬁcation as a reference [5,7–9].
Currently, two MALDI-TOF MS systems are commercially
available in Europe: Bruker MS (Microﬂex; Bruker Daltonik,
Bremen, Germany) and Shimadzu MS (AXIMA; Shimadzu
Corporation, Kyoto, Japan). The methodology of the two
systems is similar, but differences are present in the compo-
sition of the databases and application of software packages
for data analyses. The aim of this study was to compare the
performance of both systems, with 16S rRNA gene sequenc-
ing as the reference standard, for identiﬁcation of clinically
relevant anaerobic bacteria.
Materials and Methods
Settings
The measurements performed with the Bruker system were
performed at the Leiden University Medical Centre (LUMC)
and the measurements using the Shimadzu system were
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performed at the University Medical Centre Groningen
(UMCG).
Bacterial strains
Anaerobic strains were derived from clinical specimens col-
lected by the UMCG. A selection of 79 isolates from 19 dif-
ferent genera was made to include all clinically relevant
anaerobes (Table 1). Strains were stored at )80C and were
subcultured on Brucella Agar with 5% sheep blood, hemin
and vitamin K (BBA) at the UMCG. Strains were sent to the
LUMC in Stuart medium and were subcultured on Trypticase
Soy Agar with 5% sheep blood (TSA). At both centres the
strains were incubated at 35C in an anaerobic atmosphere
for 48 h prior to the measurements.
16S rRNA gene sequencing
DNA of the strains was isolated as described previously by
Boom et al. [10] and the 16S rRNA genes were ampliﬁed
and sequenced using universal 16S rRNA-speciﬁc primers
[11]. The sequences obtained were compared with
sequences present in GenBank using the Blastn.
Measurement with MALDI-TOF MS Bruker
Measurements were performed with a Microﬂex mass spec-
trometer (Bruker Daltonik) using FlexControl software (ver-
sion 3.0). Spectra were recorded in the positive linear mode
(laser frequency, 20 Hz; ion source 1, voltage at 20 kV; ion
source 2, voltage at 18.4 kV; lens voltage, 9.1 kV; mass
range, 2000–20 000 Da). Spectra were internally calibrated
daily by using Escherichia coli ribosomal proteins. The spectra
were imported into the integrated Biotyper software (ver-
sion 2.0) and were analysed by standard pattern matching
with default settings.
The strains were tested with the Bruker system both
directly and after pretreatment, both in duplicate (four mea-
surements per isolate). Pretreatment consisted of suspending
several colonies in 150 lL of distilled (RNAse-free) water.
Ethanol absolute (450 lL) was added and the sample was
centrifuged (14 000 g for 2 min). The supernatant was dis-
carded, the procedure of centrifuging was repeated, and the
remaining pellet was air-dried. The pellet was then sus-
pended in formic acid (70%; 25 lL) and acetonitrile (25 lL)
and after mixing the sample was centrifuged again (14 000 g
for 2 min). The supernatant (1 lL) was deposited on the
MALDI-plate.
For measurement without pretreatment, a colony was
directly spotted on the MALDI-plate. Pretreated and
untreated samples were overlaid with 1 lL of matrix solu-
tion (a-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile
and 2.5% triﬂuoroacetic acid) and air-dried. Measurements
were performed as described previously [9]. The Biotyper
database contained 3476 spectra and was updated until 17
February 2010. The spectrum of each isolate was com-
pared with those in the database and identiﬁcation was
provided with an accompanying score (log score 0–3) of
reliability. This score is based on (i) matching of the spec-
trum in general, (ii) matching of the locus of the peaks and
(iii) matching of the height of the peaks. Scores <1.7 repre-
sent no reliable identiﬁcation. A score ‡1.7 and <2.0 is
considered identiﬁcation at the genus level, scores ‡2.0
identiﬁcation at the species level. Of the four measure-
ments executed per isolate, the highest reliable identiﬁca-
tion was used as the deﬁnitive result. Direct results were
also analysed separately. If duplicate measurements were
equally reliable but contradictory, this was classiﬁed as ‘no
uniform result’.
Measurement with MALDI-TOF MS Shimadzu
Colonies were directly spotted on the MALDI-plate and
covered with 1 lL matrix solution (a-cyano-4-hydroxy-
cinnamic acid) and air-dried. The measurements were per-
formed with an AXIMA Conﬁdence MALDI-TOR mass
spectrometer (Shimadzu). Mass spectra were acquired in a
linear positive ion extraction mode using an acceleration of
20 kV and a low mass gate of 1500 Da. The system was cal-
ibrated externally with a mass spectrum obtained from fresh
cells of an E. coli K12 strain (CCUG). Spectra were accumu-
lated from 1000 laser pulse cycles, automatically processed
with the Shimadzu Biotech Launchpad software, and
exported to and analysed with the SARAMIS software pack-
age (AnagnosTec, Golm, Germany). The database, which
was updated until 4 February 2010, contained 2875 Super-
Spectra and 37 804 reference spectra of 701 and 1439 taxo-
nomic units, respectively. A SuperSpectrum is derived from
several reference spectra of different strains of the same
species and represents the reference peaks suitable for iden-
tiﬁcation. They were used for the fully automated identiﬁca-
tion of bacterial strains. If no identiﬁcation with a
SuperSpectrum could be obtained, measurements were
compared with the original reference spectra. Species were
separated by setting a threshold of 50% matching peaks. All
measurements were performed in duplicate and the mea-
surement with the highest percentage of matching peaks
was considered to be correct. When the percentage of
matching peaks was <50%, strains were manually identiﬁed
using the software. If a conclusive identiﬁcation was
obtained, this was accepted. If the results of two duplicate
measurements were different, while the percentage of
matching peaks was similar, they were considered to be ‘not
uniform’.
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TABLE 1. Identiﬁcation results obtained with MALDI-TOF MS using two different systems, compared with 16S rRNA gene
sequencing
Strains (n)a
Bruker (pretreatment) Shimadzu (direct)
Correct
species ID (n)
Correct
genus ID (n)
Spectra in
database (n)
Correct
species ID (n)
Correct
genus ID (n)
Spectra in
database (n)
Actinomyces
israelii (3) 0 0 0 0 0 13
meyeri (1) 0 0 1 1 1 6
naeslundii (1) 0 0 2 0 0 4
odontolyticus (2) 1 1 2 1 1 21
Anaerococcus
lactolyticus (1) 1 1 1 1 1 10
murdochii (1) 1 1 1 0 1 6
prevotii (1) 0 1 2 0 0 4
tetradius (1) 1 1 1 1 1 8
vaginalis (2) 0 2b 1 2 2 34
Atopobium
parvulum (1) 0 0 1 1 1 8
Bacteroides
dorei (2) 0 2b 0 0 2 35
fragilis (4) 4 4 9 4 4 90
ovatus (2) 2 2 4 0 2 26
thetaiotaomicron (3) 3 3 8 3 3 27
uniformis (2) 2 2 3 0 2d 48
ureolyticus (2) 0 0 0 0 0 5
vulgatus (2) 2 2 4 1 1 78
Bilophila
wadsworthia (3) 0 2 0c 3 3 15
Campylobacter
rectus (3) 0 0 0 0 0 0
Clostridium
butyricum (1) 0 0 1 1 1 4
clostridioforme (1) 0 1b 2 0 0 0
difﬁcile (2) 2 2 10 2 2 839
hathewayi (1) 0 1 0 0 0 0
perfringens (2) 2 2 9 2 2 104
ramosum (1) 1 1 4 1 1 8
septicum (1) 1 1 2 0 0 4
sporogenes (1) 1 1 3 0 1 7
Eggerthella
lenta (2) 0 0 0 0 0 6
Finegoldia
magna (3) 3 3 6 3 3 202
Fusobacterium
necrophorum (1) 1 1 2 1 1 21
nucleatum (1) 0 1 4 0 0 25
Parabacteroides
distasonis (2) 2 2 5 2 2 32
Parvimonas
micra (3) 0 1 1 3 3 153
Peptococcus
niger (1) 0 0 0 1 1 6
Peptoniphilus
gorbachii (2) 0 0 0 1 2 22
harei (3) 1 1 2 3 3 113
ivorii (1) 0 1 1 1 1 8
lacrimalis (1) 0 0 0 1 1 16
Peptostreptococcus
anaerobius (2) 2 2 2 2 2 31
stomatis (1) 0 0 0 0 1b 0
Porphyromonas
species (1) 0 0 0 0 0 0
gingivalis (1) 1 1 2 1 1 12
Prevotella
buccae (1) 1 1 1 1 1 44
nigrescens (1) 1 1 1 1 1 42
Propionibacterium
acnes (3) 3 3 5 3 3 85
propionicum (1) 0 1 1 0 0 0
Veillonella
parvula (1) 1 1 2 0 1 0c
aNumber of strains for each species.
bMinor error: correct genus, incorrect species.
cGenus present in database.
dNo uniform results.
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MALDI-TOF MS identiﬁcation vs. 16S rRNA gene
sequencing
Outcomes of MALDI-TOF identiﬁcation as compared with
the reference standard were classiﬁed as: ‘no identiﬁcation,
species present or not present in the database’, ‘major
error’, ‘minor error’, ‘correct genus identiﬁcation’, ‘correct
species identiﬁcation’ and ‘no uniform result’. ‘Major error’
represents misidentiﬁcation at the genus level; ‘minor error’
represents correct genus identiﬁcation but incorrect species.
Statistics
PASW Statistics 17.0 (SPSS Inc., Chicago, IL) was used. Chi-
square tests were used for the statistical analyses.
Results
Table 1 depicts the 79 isolates belonging to 19 genera and 47
species that were tested in both the Bruker MS and the Shi-
madzu MS systems. No effect of culture medium was found
when a subset of 58 strains was grown on both TSA and BBA
medium and subsequently tested with Bruker MS (data not
shown). In general, Shimadzu MS performed better than Bru-
ker MS (p 0.024 and p 0.139, see Table 2). When only direct
measurements were analysed, correct species identiﬁcation
occurred in 60.8% using Shimadzu and 35.4% using Bruker
MS, whereas correct genus identiﬁcation was achieved in
70.9% and 51.9%, respectively. When the results with pre-
treatment were taken into account, the outcomes of Bruker
MS improved to correct species identiﬁcation of 50.6% and
correct genus identiﬁcation of 60.8% of the isolates.
The number of strains that could not be identiﬁed
because of absence in the database was signiﬁcantly larger
for the Bruker system as compared with the Shimadzu sys-
tem (19.0% vs. 7.6%, p 0.035).
Results for the various species
With the Bruker system duplicate measurements yielded
uniform results. Results of Shimadzu MS were not uniform
for two isolates (2.5%), both concerning Bacteroides uni-
formis. The ﬁrst was manually identiﬁed as B. uniformis
and B. fragilis, the second as B. uniformis, B. fragilis and
Bacteroides sp.
The overall results are representative of the results for
the various genera, except for the Bacteroides fragilis group
and Gram-positive anaerobic cocci (GPAC). The Bruker sys-
tem showed a signiﬁcantly higher percentage of correct spe-
cies identiﬁcation of members of the Bacteroides fragilis group
than the Shimadzu system; 87% (13 out of 15, no difference
between pretreated and direct measurement) and 53% (8
out of 15, p 0.046), respectively. On the other hand, the Shi-
madzu system performed signiﬁcantly better for the identiﬁ-
cation of GPAC (p <0.05). Of the 24 isolates in this group,
including Anaerococcus spp., Atopobium parvulum, Finegoldia
magna, Parvimonas micra, Peptococcus niger, Peptoniphilus spp.
and Peptostreptococcus spp., only three (12.5%) were cor-
rectly identiﬁed at the species level and nine (37.5%) at the
genus level by direct measurement with Bruker MS. With
pretreatment these percentages increased to 37.5% (n = 9)
and 50% (n = 12), respectively. Direct measurements with
Shimadzu MS reached much higher levels of correct species
(n = 20, 83%) and genus identiﬁcation (n = 22, 92%).
Two major errors occurred with Bruker MS: Actinomyces
israelii (not in the database) was misidentiﬁed as Lactobacillus
catenaformis and Actinomyces naeslundii was misidentiﬁed as
Neisseria gonorrhoea. Shimadzu MS erroneously determined
Campylobacter rectus (not in the database) as being Staphylo-
coccus aureus (n = 1) and Fusobacterium nucleatum as Clostrid-
ium sp. (n = 1). Only Actinomyces israelii was repeatedly
misidentiﬁed.
Minor errors by the Bruker system were: Anaerococcus hy-
drogenalis instead of A. vaginalis (n = 2, only with pretreat-
ment), Bacteroides vulgatus instead of B. dorei (n = 2, not in
the database) and Clostridium hathewayi instead of C. clostridio-
forme (n = 1). Log scores of these ﬁve strains were not sig-
niﬁcantly different from the log scores of 10 strains that
were correctly identiﬁed to these particular species (data
not shown). The one minor error by Shimadzu was: Pepto-
streptococcus anaerobius instead of P. stomatis (n = 1, not in
the database).
Discussion
MALDI-TOF MS is a promising tool for the identiﬁcation
of bacteria that can only be identiﬁed using elaborate
TABLE 2. Results of identiﬁcation by MALDI-TOF MS
Bruker and Shimadzu
Bruker
Direct,
n = 79 (%)
Bruker
Including
pre-treatment,
n = 79 (%)
Shimadzu
Direct,
n = 79 (%)
Major errora 2 (2.5) 2 (2.5) 2 (2.5)
Minor errorb 3 (3.8) 5 (6.3) 1 (1.3)
No id, present in database 18 (22.8) 9 (11.4) 12 (15.2)
No id, not in database 15 (19) 15 (19) 6 (7.6)
Correct genus 41 (51.9) 48 (60.8) 56 (70.9)
Correct species 28 (35.4) 40 (50.6) 48 (60.8)
No uniform results 0 (0) 0 (0) 2 (2.5)
p-valuec 0.024 0.139
aIncorrect genus identiﬁcation.
bCorrect genus, incorrect species identiﬁcation.
cBruker vs. Shimadzu.
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phenotypic determination methods, such as anaerobes. In
this study, two commercially available MALDI-TOF MS sys-
tems were compared using 16S rRNA gene sequencing as
the reference standard. Identiﬁcation of anaerobes by Shima-
dzu was better, due to the need for pretreatment of the
samples in Bruker’s methodology and differences in the com-
position of the databases.
A limitation of this study is the relatively small number of
isolates per species. Therefore, we focused on the overall
results and on two selections of isolates: GPAC and the
Bacteroides fragilis group. Strengths of this study are the
wide range of clinically relevant anaerobes tested and the
use of 16S rRNA gene sequencing as the reference stan-
dard. In addition, this study is the ﬁrst analysis of two dif-
ferent MALDI-TOF MS systems for performance on
anaerobic bacteria. Cherkaoui et al. [7] compared Bruker
and Shimadzu MS for a variety of mainly aerobic bacteria
and found high-conﬁdence identiﬁcation in 94.4% and 88.8%,
respectively, >99% of which was correct. However, only a
small number of anaerobic bacteria were included and iden-
tiﬁcation was only reported at genus level. The majority of
studies that included anaerobes in comparing MALDI-TOF
MS with standard identiﬁcation [5,7–9], used phenotypic
identiﬁcation as the ﬁrst line reference. When discrepancies
were found, 16S rRNA gene sequencing was performed. A
disadvantage of this approach is that if the results of MS
and biochemical tests are incorrect but similar, this error
will not be noted.
The performance of MALDI-TOF MS in bacterial identiﬁ-
cation is known to depend highly on the quality of the
database present in the software that accompanies the sys-
tem [8,9,12]. At the moment of this study, the Shimadzu
system contained more reference spectra than the Bruker
system, which explains the better performance. This was
supported by two ﬁndings. First, when strains not present
in the database were excluded from the analyses for each
database, the Shimadzu and Bruker systems performed
equally well, with respectively 76.7% and 75.0% correct
genus identiﬁcation. Secondly, in May 2010 Bruker provided
the LUMC with an update of the database (upgrade from
3476 to 3740 spectra). Comparing the measured peaks of
all isolates with the spectra in the updated database led to
a remarkable improvement of the results: 63.3% correct
species identiﬁcation and 72.2% correct genus identiﬁcation
(measurements after pretreatment). The percentage of iso-
lates that could not be identiﬁed due to current absence of
reference spectra decreased from 19% to 7.6%. Both the
Bruker and Shimadzu system would beneﬁt from further
expansion of their databases, to cover this ﬁnal 7.6% of
strains. However, a signiﬁcant number of species remains
unidentiﬁed even though the database contains their refer-
ence spectra (Bruker, 10–11%; Shimadzu, 15%). For the
Bruker system this may be explained by variation within
species and the small number of spectra per species that
are currently available. For the Shimadzu system, strains
that could not be identiﬁed in spite of available reference
spectra are generally represented by <10 spectra (see
Table 1). Nevertheless, it is unclear why the Shimadzu sys-
tem cannot recognize F. nucleatum and A. israelii, with 25
and 13 reference spectra, respectively. Perhaps pretreat-
ment would improve the results, in line with our ﬁndings
for the Bruker system.
Two differences in identiﬁcation results between the Bru-
ker and Shimadzu systems were clearly observed: Bruker MS
performed better for Bacteroides spp, while Shimadzu MS
performed better for the identiﬁcation of GPAC. Nagy et al.
[5] previously showed that Bruker MS was superior to phe-
notypic identiﬁcation for members of the Bacteroides fragilis
group. B. dorei, which in our study was erroneously identiﬁed
by Bruker MS as B. vulgatus, was not included in the study by
Nagy et al. As B. dorei and B. vulgatus share the same bio-
chemical features, it might be possible that the same ‘minor
error’ has occurred in the study reported by Nagy et al., but
remained unnoticed. It is unclear why Shimadzu MS performs
less well on Bacteroides spp, especially considering the large
number of spectra for this genus in the reference database
(Shimadzu, 304; Bruker, 28). The superior results of Shima-
dzu regarding GPAC may be explained by the fact that the
Shimadzu database is more extensive.
Bruker MS measurements were performed with and with-
out pretreatment, as this mimics the diagnostic routine at
the LUMC (for clinical specimens, if no direct result is
obtained the measurement is repeated with pretreatment).
Measurements with and without pretreatment resulted in
identical results if a log score of ‡1.7 was assigned. In gen-
eral, pretreatment raised the log scores. In two cases this
led to a minor error instead of correct genus identiﬁcation,
but overall pretreating the samples increased the percentage
of correctly identiﬁed, mainly Gram-positive strains. This
may be explained by the thicker peptidoglycan layer of
Gram-positive bacteria, which may interfere with the laser
ionisation. Cherkaoui et al. [7], comparing the performance
of the Shimadzu and Bruker systems for aerobes and anaer-
obes, noted that isolates not identiﬁed by MALDI-TOF MS
were mostly Gram-positive bacteria. In contrast, Van Veen
et al. [9] noted that pretreatment for Gram-positive bacteria
was not necessary using the Bruker system. Grosse-Herren-
they et al. [4] used pretreatment for clostridial identiﬁcation
with the Bruker system, but did not test it against direct
measurement.
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In contrast to the Bruker methodology, pretreatment of
samples does not seem necessary with the Shimadzu system.
There might be several reasons for this. First, in the Bruker
database only reference spectra of pretreated strains are
present, while the Shimadzu database contains spectra
obtained without pretreatment. Secondly, the ‘time of ﬂight’
for the Shimadzu system is longer than for the Bruker sys-
tem, which may result in a more distinct peak pattern. A
major disadvantage of pretreatment is the prolongation of
the turnaround time. The turnaround time for one sample is
approximately 5 min for both MS systems, which is pro-
longed to 35 min with pretreatment.
Bacterial identiﬁcation by Shimadzu MS is based on com-
parison of the measured spectrum with SuperSpectra and
reference spectra. If the percentage of matching peaks is
<50%, manual identiﬁcation can be performed. The results of
manual identiﬁcation are less favourable than those achieved
by automated identiﬁcation (data not shown). However, it
contributes to a higher rate of identiﬁcation, while this
opportunity is not used by the Bruker system, which may
explain another small part of the difference in performance
between the systems.
Based on our study, we can not yet recommend imple-
menting MALDI-TOF MS for routine identiﬁcation of anaero-
bic bacteria in clinical microbiology. However, the study was
not designed to evaluate the potential advantages of MALDI-
TOF identiﬁcation over currently used methods. If MALDI-
TOF MS is applied, simple microbiological tests such as
Gram-staining are still required to recognize major errors
made by MS. MALDI-TOF systems need optimization, (i) by
adding reference spectra of bacteria that are not yet repre-
sented, (ii) by expanding the number of available spectra per
species, and (iii) by gaining insight into the reasons why iden-
tiﬁcation sometimes fails, even with sufﬁcient reference spec-
tra present in the database. We are conﬁdent that this will
ultimately lead to a method of rapid identiﬁcation of most
clinically relevant anaerobic bacteria.
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